E-Cigarette Use May Increase COPD Risk
Electronic cigarette (e-cigarette) use may be associated with an increased risk of chronic obstructive pulmonary disease (COPD).
Electronic cigarette (e-cigarette) use may be associated with an increased risk of chronic obstructive pulmonary disease (COPD).
Electronic cigarette use is associated with lifetime asthma in US adolescents, and may become more damaging when combined with marijuana or cigarette smoking.
The United States Preventive Services Task Force recommends that primary care clinicians provide interventions to prevent the initiation of smoking in the pediatric population.
Organizations including the CDC and FDA have been investigating the nationwide outbreak of e-cigarette or vaping product use–associated lung injury since August 2019.
Officials say teen had ‘chronic underlying medical condition,’ but condition has not been identified.
CDC will no longer monitor nonhospitalized patients due to similarities with hospitalized cases.
The number of Americans stricken with a severe, sometimes fatal lung illness tied to vaping has now reached 1888.
First use of menthol, mint, or other flavored cigarette vs nonflavored cigarette tied to later cigarette use.
Guidelines highlight importance of asking patients about e-cigarette, or vaping, use in nonjudgmental way.
And, 26 vaping-related deaths across 21 states have now been reported.